A clearer way to explore peptide research EDUCATION · EVIDENCE · CALCULATIONS

Names are a starting point. Evidence is the next step.

Compound Library

Find a name, follow its sources, and keep the limits of what is known in view.

69 names in the index

This index includes peptides and related compounds. An entry is a research starting point, not an endorsement, approval status or dosing protocol. Entries without a source note have not received a compound-specific review here.

5-Amino-1MQ

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Abaloparatide

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Adamax

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Adipotide

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

AHK-Cu

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

AICAR

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

AOD-9604

SOURCE NOTE

FDA notes limited safety information and potential immune-reaction risks.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

ARA-290

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

BPC-157

SOURCE NOTE

FDA highlights limited safety information and potential immune-reaction risks.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Bronchogen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Cagrilintide

SOURCE NOTE

FDA states cagrilintide has not been found safe and effective for any condition.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Cardiogen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Cartalax

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Cerebrolysin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Chonluten

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

CJC-1295 DAC

SOURCE NOTE

FDA reports serious adverse events associated with CJC-1295; clinical data are limited.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

CJC-1295 No DAC

SOURCE NOTE

Check molecular identity carefully; FDA’s CJC-1295 notice is not evidence for every similarly named product.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Cortagen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

DSIP

SOURCE NOTE

FDA lists emideltide (DSIP) with safety-data limitations.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Eloralintide

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Epitalon

SOURCE NOTE

FDA describes missing safety information for the proposed route.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

FOXO4-DRI

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

GHK-Cu

SOURCE NOTE

FDA identifies limited human safety data for injectable GHK-Cu.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

GHRP-2

SOURCE NOTE

FDA identifies safety concerns for injectable and nasal administration.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

GHRP-6

SOURCE NOTE

FDA notes safety concerns, including effects on glucose regulation.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Glutathione

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Gonadorelin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

HCG

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

HGH 191AA

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

HMG

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Humanin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

IGF-1 LR3

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Ipamorelin

SOURCE NOTE

FDA flags gaps in safety information for some injectable routes.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Kisspeptin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

KPV

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

L-Carnitine

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Livagen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

LL-37

SOURCE NOTE

FDA describes safety uncertainties and concerning nonclinical findings.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Mazdutide

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Melanotan I

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Melanotan II

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

MGF

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

MOTS-C

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

NAD+

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Ovagen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Oxytocin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

PE-22-28

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

PEG MGF

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Pinealon

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

PNC-27

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Prostamax

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

PT-141

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Retatrutide

SOURCE NOTE

FDA states retatrutide is not a component of an approved drug.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Selank

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Semaglutide

SOURCE NOTE

Approved and unapproved formulations are not interchangeable; verify the exact product and instructions.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Semax

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Sermorelin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

SLU-PP-332

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

SNAP-8

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

SS-31

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Survodutide

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

TB-500

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Teriparatide

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Tesamorelin

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Testagen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Thymosin Alpha-1

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Tirzepatide

SOURCE NOTE

FDA has reported concerns about unapproved products and dosing errors.

Read the FDA source ↗

Source checked November 5, 2026. Consult the linked page for updates and its exact scope.

Search PubMed for this name ↗How to evaluate what you find →

Vesugen

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

Vilon

RESEARCH STARTING POINT

Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.

Search PubMed for this name ↗How to evaluate what you find →

A name isn’t the whole story.

Learn to distinguish a promising finding from a reliable conclusion.

Understand the evidence ↗